Skip to content
Screener

Haemonetics HAE Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

Abbott logo
AbbottABT
$486M+73.6%
TFX
TeleflexTFX
$3.2M-22.0%
LivaNova logo
LivaNovaLIVN
$10.72M-16.6%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$300K
ITG
Integer HoldingsITGR
$600K+50.0%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation

See full
Market cap$3.94B+55.9%
Enterprise value$4.89B+41.4%
P/E26.2×-10.7×
P/S2.9×+1.0×

Profitability

See full
Gross margin59%+2.1pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:09 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000313143-26-000120
Line itemJune 27, 2026March 28, 2026
ASSETS
Current assets:
Cash and cash equivalents$223,384$245,440
Accounts receivable, less allowance for credit losses of $3,618 as of June 27, 2026 and $3,693 as of March 28, 2026216,071216,855
Inventories, net306,739306,370
Prepaid expenses and other current assets64,63866,214
Total current assets810,832834,879
Property, plant and equipment, net303,778305,761

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's allowance for doubtful accounts receivable (current)?
Haemonetics (HAE) reported allowance for doubtful accounts receivable (current) of $3.62M in Q2 2026.
How has Haemonetics's allowance for doubtful accounts receivable (current) changed year-over-year?
Haemonetics's allowance for doubtful accounts receivable (current) decreased by 42.7% year-over-year, from $6.32M to $3.62M.
What is the long-term trend for Haemonetics's allowance for doubtful accounts receivable (current)?
Over 5 years (2021 to 2026), Haemonetics's allowance for doubtful accounts receivable (current) has grown at a 10.7% compound annual growth rate (CAGR), from $2.23M to $3.69M.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about Haemonetics's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude